Telehealth Watch List.
We Haven't Looked at the Telehealth Watch List for a Spell and we Were Very Surprised at the YTD Performance.
OMNIQ (OMQS) Graduates to NASDAQ. And Three Wall Street Research Reports Follow.
Wall Street Brokerage Price Target Estimates of $15 - $18 Per Share.
Without disrupting legacy sales - CEO Shai...
OMNIQ (OMQS) to Begin Trading on NASDAQ
100% Here, 100% There, Pretty Soon it all Adds up. Our Sixth Client to Graduate to NASDAQ.
Yes, some...
Adding Amplitech Group (AMPG) $5.04 to Watch List.
LIVE QUOTE
Now locked...
GBT Technologies (GTCH) Aims to Power Wearable GPS Tracker for Seniors.
GOPHER | GBT TECNOLOGIES
https://youtu.be/9ovYCMHmOi8
GBT Technologies and GTX Corp. Enter into...
Adding GBT Technologies (GTCH) to the Watch List.
Massive Potential From California Based Technology Think Tank.
Yes, risky - as in...
GBT (GTCH) Is Researching To Develop An AI Empowered, Wireless Patient Health Monitoring System
The researched technology, is aiming to create a Radio-Based patient health monitoring system for homes or facilities
SAN...
Goldman Sachs Likes the Drone Industry, and So Do We.
GOLDMAN SACHS INSIGHTS: DRONES
SPECIAL REPORT
Adding Draganfly (DFLYF) $1.40 to Watch List.
Amnnounces Deal to Supply 3,000 Drones to Steve Wozniak via 'Woz EDU" Partnership.
Two of Our $5.00 Watch List Stocks Double, in Like Just Five Months!
Added to the Watch List in November, OMNIQ (OMQS) and Galaxy Digital (GLXY) Shine like a Pretty Penny, with OMNIQ Doubling...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
